THE ENFORCEMENT PARADOX: WILL THE HEMP BAN FOLLOW MARIJUANA’S PATH?

A Congressional Research Service analysis published in December raised a question the hemp industry has been whispering about for months: will the ban actually be enforced?

The CRS report suggests that both the FDA and DEA ‘may lack the resources to broadly enforce the new prohibitions.’ It draws a direct parallel to the wider cannabis industry, noting that despite marijuana remaining federally illegal as a Schedule I substance, ‘the federal response has largely been to allow states to implement their own marijuana laws despite the fact that state-regulated activities may violate the Controlled Substances Act.’

If intoxicating hemp products persist after November 2026, they could face the same consequences as marijuana: banking restrictions, interstate commerce limitations, and theoretical federal prosecution exposure—though the likelihood of broad enforcement remains uncertain.

This creates a strange kind of regulatory purgatory. Products that are illegal on paper may continue to exist in practice, particularly in states that have their own hemp regulatory frameworks. The uncertainty itself becomes a form of regulation—driving compliant businesses out while leaving less scrupulous operators in the market.

The irony is profound: the same enforcement gap that allowed the hemp market to grow uncontrolled may now preserve it, albeit in diminished and legally precarious form.